1510 related articles for article (PubMed ID: 6298039)
1. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
2. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
3. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
5. Effect of propranolol on delayed glucose recovery after insulin-induced hypoglycemia in normal and diabetic subjects.
Kleinbaum J; Shamoon H
Diabetes Care; 1984; 7(2):155-62. PubMed ID: 6376011
[TBL] [Abstract][Full Text] [Related]
6. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
9. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
[TBL] [Abstract][Full Text] [Related]
10. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
11. Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus.
Sigal RJ; Fisher SJ; Halter JB; Vranic M; Marliss EB
J Clin Endocrinol Metab; 1999 Nov; 84(11):3961-71. PubMed ID: 10566635
[TBL] [Abstract][Full Text] [Related]
12. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
Hirsch IB; Boyle PJ; Craft S; Cryer PE
Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
[TBL] [Abstract][Full Text] [Related]
13. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
Boyle PJ; Shah SD; Cryer PE
Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic influence on glucocounterregulation in man.
Lilavivat U; Brodows RG; Campbell RG
Diabetologia; 1981 Apr; 20(4):482-8. PubMed ID: 7016643
[TBL] [Abstract][Full Text] [Related]
15. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
[TBL] [Abstract][Full Text] [Related]
16. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
Davis MR; Shamoon H
Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
[TBL] [Abstract][Full Text] [Related]
17. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
[TBL] [Abstract][Full Text] [Related]
18. Attenuated glucose recovery from hypoglycemia in the elderly.
Marker JC; Cryer PE; Clutter WE
Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
[TBL] [Abstract][Full Text] [Related]
20. Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man.
Lauridsen UB; Christensen NJ; Lyngsøe J
J Clin Endocrinol Metab; 1983 May; 56(5):876-82. PubMed ID: 6339540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
